Peginterferon Alfa-2a in Patients with Chronic Hepatitis C

20001,224 citationsJournal Articlebronze Open Access

Authors

Stefan Zeuzem · Goethe University Frankfurt

S.V. Feinman · Mount Sinai Hospital

J. Rasenack · University Medical Center Freiburg

E. Jenny Heathcote · Toronto Western Hospital

Ming–Yang Lai · National Taiwan University Hospital

Edward Gane · Middlemore Hospital

John O’Grady ·

Abstract

In patients with chronic hepatitis C, a regimen of peginterferon alfa-2a given once weekly is more effective than a regimen of interferon alfa-2a given three times weekly.

Topics & Keywords

Hepatitis C virus research Systemic Lupus Erythematosus Research Monoclonal and Polyclonal Antibodies Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 343, Issue 23, pp. 1666-1672

DOI: 10.1056/nejm200012073432301

Field-Weighted Citation Impact: 67.89